Drug Trial Radar · NCT05077462
A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Oct 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
60
Planned (sponsor's estimate)
Start
Sep 17, 2021
Primary completion
Apr 30, 2022
Study completion Apr 30, 2022
Sponsor
- Lead sponsor
- AJU Pharm Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 14, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate the safety and pharmacokinetic characteristics of AJU-C52H in healthy adults
Conditions
- Hypertension
Interventions
C52R1M Tab. and C52R2 Tab.Drug
Single oral dose C52R1M(FDC, Valsartan/Amlodipine) 160/5 mg tablet and C52R2(Chlorthalidone) 25 mg tablet taken together
AJU-C52HDrug
Single oral dose AJU-C52(Valsartan/Amlodipine/Chlorthalidone) 160/5/25 mg FDC tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- AUCt of AJU-C52Time frame: Pre-dose (0 hour), 0.5, 1, 2, 2.5, 3, 3.5, 4, 5, 6, 7, 8, 10, 12, 24, 48, 72 hours
- Cmax of AJU-C52Time frame: Pre-dose (0 hour), 0.5, 1, 2, 2.5, 3, 3.5, 4, 5, 6, 7, 8, 10, 12, 24, 48, 72 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
H+ Yangji Hospital
Seoul, Republic of South Korea, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.